focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
Why did you multiply earnings by 0.365?
The twitter page's latest post has got Kistos earning 275 million euros at current spot prices. Kistos market cap is around 340 million euros.
Pretty close. PE of 1.2.
What's your disagreement?
If these numbers were true, then Kistos would have shown a lot more cash on their balance sheet during this business update a week or two ago? Note those numbers came out before the windfall taxes hit. If the company is trading at a 1x PE, I don't think it matters with windfall taxes, the stock would be much much higher...
New to UK stocks - is it required for all LSE listed companies to show when they buy back shares? I just found the RNS site for Indivior, and I didn't realize they report buyback activity on a daily basis.
https://twitter.com/Kistos_Pears
Does anyone follow this page? Looks like some kind of robot that tries to estimate how much Kistos is earning at spot prices...no way those numbes are correct? High windfall taxes or not, its implying stock is at a PE of 1.
Of course, right after I first build up my position, the stock falls lol
Hi, the document you referenced actually says "• Adjusted operating profit expected to be modestly higher than FY 2021’s adjusted operating profit of $187m (previously “broadly similar” to FY 2021 adjusted operating profit of $187m)."
Can you tell me where you saw $205 million for 2021's operating profit?
Got it. And thank you! I assume a lot of money will flow into this stock once it gets listed on the NASDAQ. Only concern is why YTD 2022 Q3 profitability is worse vs. 2021, despite revenue growth. Any thoughts?
Also, their YTD profit numbers are below 2021. Any idea why?
Oh wow that’s 2022’s, correct? So 2023 numbers will be even higher. Also, US investor here…what does RNS mean? And the stock is literally climbing every single day. This is crazy. I keep waiting for a small pullback.
"Additional EPL was announced at the end of November, there aren't any corp tax installment payment dates between then and the end of the year, so that wouldn't affect year end cash position."
So then their cash generation looks even worse between August and December?...the tax payment didn't hit last year, yet their cash generation was very weak relative to all the estimates given where spot nat gas was in Europe. This feels like a red flag, no?
Thanks - just read it. Unfortunately, it doesn't really answer how much the company might earn this year?
Yes fair enough, but no one expected TTF to fall into the 60’s in the winter either?
Anyone have a rough idea on what they will earn this year / what multiple the stock is currently trading at? Also, seems like once this company gets up listed to the USA, there’s a strong chance it will get bought out by a bigger pharma? Sublocade headed for $1 billion in revenue has to be worth at least $5 billion to a strategic?
I thought the estimates were that they would earn their entire market cap in the second half of last year? In that regard, this update feels a little underwhelming, no?
So TTF is in the 60' now? The Kistos writeups I saw last year assumed TTF in the 80's for 2023. How much downside protection do we have at this price?